New Year, New You! Health is at the top of many people’s resolutions for 2016, including ours at Johnson & Johnson. “We must set the standard for a healthier world,” says Alex Gorsky, our Chairman and CEO, “by moving the needle on creating healthier societies. Health is not a privilege; it’s a basic human right.”
That’s why J&J is looking forward to this year’s JP Morgan Health Care Conference in San Francisco. Alex and senior leaders will discuss how J&J is moving that needle as the world’s largest broadly-based health care company. The conference kicks off on Monday, January 11 and will bring together top thought leaders from around the world for a robust discussion about the current state and future potential of health care.
We’ll have a strong presence at the conference, leading groundbreaking discussions on our collective mission to move the world towards a healthy society.
Chairman and CEO Alex Gorsky will lead the discussion about health care being one of society’s greatest challenges … and opportunities. He will discuss how a culture of health and wellness are the keys to a future where people are healthier and businesses and economies are stronger as a result.
Chief Scientific Officer Dr. Paul Stoffels will discuss how driving a culture of relentless innovation and a commitment to forging agile and effective partnerships are creating bigger, better and faster health care breakthroughs to treat and eradicate life-threatening diseases, including Ebola, Tuberculosis and HIV.
READ: Johnson & Johnson is committed to combating Ebola, including the start of a clinical trial in Sierra Leone for a preventive vaccine.
Sandi Peterson, Group Worldwide Chairman, will discuss how the emerging intersection of technology and health is improving people’s daily health AND empowering patients, doctors, hospitals and payers.
Dominic Caruso, Chief Financial Officer, will discuss the need to change economic perceptions about health care. “When health care is seen as an investment instead of a cost, we will improve people’s health and productivity and, thereby, return dividends to business and to society.”
We believe being broadly based in health care has been and will continue to be a significant factor in Johnson & Johnson’s success as it positions us to lead in the evolving health care landscape and to be the partner of choice in health care given the breadth of our products, services, capabilities and technologies. J&J has a long-standing legacy of commitment and partnership to improve global public health for individuals, families and communities worldwide.
You can follow the latest developments at the JP Morgan conference on Twitter via @JNJNews, @JNJInnovation and hashtag #JPM16. There will also be a webcast available of Alex’s remarks for investors and other interested parties that can be accessed at www.investor.jnj.com.